Overview


According to FutureWise analysis the market for epilepsy devices in 2023 is US$ 0.74 billion, and is expected to reach US$ 1.13 billion by 2031 at a CAGR of 5.32%.

Epilepsy is a neurological disorder characterized by abnormal brain activity, resulting in seizures, unusual behaviors, or loss of awareness. It is caused by a variety of conditions such as convulsions and epileptic seizures, such as atonic seizures, myoclonic seizures, and tonic-clonic seizures. Epilepsy devices are in demand because people are becoming more aware of panic attack treatment. Global epilepsy monitoring devices market growth is hindered by the high cost of epilepsy monitoring operations and devices, especially in developing countries without adequate reimbursement systems. Additionally, brain monitoring equipment is often expensive and highly complex, which adds to the complexity of the procedures. Mergers and acquisitions by market key players to expand the existing product portfolio are expected to create opportunities in the global epilepsy device market.Additionally, there are a variety of preventive health care and health programs available, variations in the medical infrastructure, and a rise in incidents of birth-related injuries and traffic accidents. Consequently, the growing cases of epilepsy around the world have led to a need for effective medical solutions that ultimately fuel the growth of the market. Certain people can develop epilepsy due to strokes, trauma, brain tumors, infections, or birth defects. Since epilepsy is more prevalent in children, general practitioners are more likely to see patients with the condition. An electroencephalogram (EEG) is used in the diagnosis of epilepsy, as are magnetic resonance imaging tests, computed tomography scans, and complete blood counts.

Epilepsy is treated with novel treatment alternatives through the use of therapeutic gadgets. Parents have a difficult time keeping track of their children's epilepsy when they develop it. Healthcare companies have developed devices that assist parents and persons with epilepsy. Users can monitor seizures and prevent catastrophic adverse effects with these gadgets. It is unknown what causes epilepsy in the majority of cases. Minimally invasive treatments are becoming more popular as patients become aware of their benefits. The use of epilepsy monitoring devices eliminates the hazards and discomfort associated with invasive brain monitoring. Government programs also aim to reduce the risks associated with brain illness treatment alternatives. Due to the increase in demand, the epilepsy monitoring devices market has growth potential.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Epilepsy Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Epilepsy Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Medpage Ltd
  • Cerbomed GmbH
  • Liva Nova
  • MC10
  • Empatica Inc
  • Neuropace inc
  • Medtronic Plc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Wearbale Devices
  • Coventional Devices
  • Implantable Devices

By Technology

  • Vagus Nerve Stimulation
  • Responsive Neurostimulation
  • Deep Brain Stimulation
  • Accelerometry

By Epilepsy Detection and Prediction Devices

  • Electroencephalogram (EEG)
  • Intracranial EEG
  • Surface electriomyography (sEMG)
  • Electrodermal Activity (EDA)
  • ELECTROCARDIOGRAPHY (EKG)
  • Video Detection Systems
  • Implanted Advisory Systems
  • Others

By End-user

  • Hospitals
  • Neurology Centers
  • Others

By Region

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Epilepsy Devices Market By Product Type, By Technology, By Epilepsy Detection
  • Prediction Devices, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Epilepsy Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Epilepsy Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Epilepsy Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Epilepsy Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Wearbale Devices
        2. Coventional Devices
        3. Implantable Devices

  • 8.   Epilepsy Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Vagus Nerve Stimulation
        2. Responsive Neurostimulation
        3. Deep Brain Stimulation
        4. Accelerometry

  • 9.   Epilepsy Devices Market, By Epilepsy Detection and Prediction Devices Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Electroencephalogram (EEG)
        2. Intracranial EEG
        3. Surface electriomyography (sEMG)
        4. Electrodermal Activity (EDA)
        5. ELECTROCARDIOGRAPHY (EKG)
        6. Video Detection Systems
        7. Implanted Advisory Systems
        8. Others

  • 10.   Epilepsy Devices Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Neurology Centers
        3. Others

  • 11.   North America Epilepsy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Epilepsy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Epilepsy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Epilepsy Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Koninklijke Philips N.V.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Nihon Kohden Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Medpage Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cerbomed GmbH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Liva Nova
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. MC!0
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Empatica Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Neuropace inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Medtronic Plc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients